Dr. Bashar Alkhalidi

Experience & Activities

Guiding Excellence  Inspiring Innovation: Dr. Bashar Alkhalidi – Your Pillar in Pharmaceutical Consultation

With a distinguished career spanning over 26 years in the pharmaceutical industry, Dr. Bashar Alkhalidi stands as a seasoned professional and academic. Holding key leadership positions, he served as the Quality and Scientific Director at Pioneer Pharmaceuticals, overseeing research and development while implementing stringent quality standards. Driven by a commitment to excellence, he recommended and designed new products, reorganized Quality Assurance and Control departments, and introduced core business concepts to enhance operational efficiency. As a Global Pharma Key Opinion Leader for Korea Health Industry Development Institute, Dr. Alkhalidi has been instrumental in providing invaluable guidance to Korean pharmaceutical companies. Leveraging his expertise, he actively participates in global symposiums, fostering open discussions on regulatory approval processes and global marketing strategies.

Furthermore, his role as a Subject Matter Expert at Price Waters & Coopers underscored his proficiency in Lean methodologies, leading Operational Excellence projects and optimizing processes. Noteworthy additions to Dr. Alkhalidi’s illustrious career include his tenure as a Technical Consultant at Jerash Pharmaceuticals and Oubari Pharmaceuticals, Amman, Jordan. In these roles, he played a pivotal role in establishing Research and Development departments, implementing new production lines, and overseeing technical and quality matters. Additionally, as an Assistant Director General at The Arab Company for Drug Industries and Medical Appliances (ACDIMA), Dr. Alkhalidi demonstrated exceptional leadership by overseeing pharmaceutical projects, executing strategic plans for business growth, conducting due diligence, and representing the company in annual board meetings. These experiences further solidify his reputation as a trusted expert with a comprehensive understanding of the pharmaceutical industry.